The Relationship With Mad Honey Containing Grayanotoxin and Ovary Tissue
Launched by CELAL BAYAR UNIVERSITY · Nov 30, 2022
Trial Information
Current as of May 19, 2025
Completed
Keywords
ClinConnect Summary
This clinical trial is studying the effects of mad honey, which contains a substance called grayanotoxin, on the ovarian tissue of female rats. The researchers want to understand how this special type of honey might influence ovarian health, particularly in the context of ovary disease. In the study, healthy female rats were divided into three groups: one group received mad honey, another received regular honey, and the third group did not receive any honey at all. After 30 days, the researchers looked at the ovarian tissues to see if there were any differences.
The trial is currently recruiting and is focused on female rats that are healthy and not experiencing any health issues. It's important to note that the rats involved in the study should be in good health and eating well. If you have a pet rat or a family member who is considering participation, they should be aware that the study involves giving the rats a specific type of honey for a month, followed by a procedure to collect tissue samples for analysis. This research could provide insights into how mad honey affects ovarian health.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • healthy rats
- Exclusion Criteria:
- • patient rats
- • not eating rats
About Celal Bayar University
Celal Bayar University is a prominent academic institution dedicated to advancing medical research and clinical practice. With a strong emphasis on innovation and collaboration, the university sponsors clinical trials aimed at exploring new therapeutic approaches and improving patient outcomes. Leveraging its state-of-the-art facilities and a team of experienced researchers, Celal Bayar University fosters an environment that promotes scientific inquiry and ethical standards in clinical research, contributing significantly to the body of medical knowledge and the development of effective healthcare solutions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yunusemre, Mani̇sa, Turkey
Patients applied
Trial Officials
Gulsen Gurgen
Study Chair
Manisa Celal Bayar University
Suha Turkmen
Study Chair
Karadeniz Teknik University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials